Opioid-Induced Constipation (OIC) Treatment Market Report

Global and China Opioid-Induced Constipation (OIC) Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 14, 2022
  • PAGES：224
  • REPORT CODE：GMM1464072
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Opioid-Induced Constipation (OIC) Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • AIKO Biotechnology

    • Takeda Pharmaceutical Company Limited

    • Salix Pharmaceuticals, Inc

    • GlaxoSmithKline, Inc

    • Cubist Pharmaceuticals

    • AstraZeneca plc, Inc

    • Pfizer, Inc

    • SLA Pharma AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Parenteral (Subcutaneous Injection)

    Application:

    • Drug Store

    • Independent Pharmacies

    • Hospital Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Opioid-Induced Constipation (OIC) Treatment Industry Overview

      • 1.1.1 Opioid-Induced Constipation (OIC) Treatment Market Scope and Market Segments

      • 1.1.2 Opioid-Induced Constipation (OIC) Treatment Industry Characteristics

      • 1.1.3 Global and China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Opioid-Induced Constipation (OIC) Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Parenteral (Subcutaneous Injection)

    • 1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Drug Store

      • 1.3.2 Independent Pharmacies

      • 1.3.3 Hospital Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Opioid-Induced Constipation (OIC) Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Opioid-Induced Constipation (OIC) Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Opioid-Induced Constipation (OIC) Treatment Industry PEST Analysis

    • 2.3 Opioid-Induced Constipation (OIC) Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Opioid-Induced Constipation (OIC) Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Opioid-Induced Constipation (OIC) Treatment Industry

    Chapter 3 Global and China Opioid-Induced Constipation (OIC) Treatment Market, by Manufacturer

    • 3.1 Global and China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Opioid-Induced Constipation (OIC) Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Opioid-Induced Constipation (OIC) Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Opioid-Induced Constipation (OIC) Treatment Market Top 3 Players

    Chapter 4 Global and China Opioid-Induced Constipation (OIC) Treatment Market, by Type (2017-2028)

    • 4.1 Opioid-Induced Constipation (OIC) Treatment Market Trend, by Type

    • 4.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Opioid-Induced Constipation (OIC) Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Opioid-Induced Constipation (OIC) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Opioid-Induced Constipation (OIC) Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Opioid-Induced Constipation (OIC) Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Opioid-Induced Constipation (OIC) Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Opioid-Induced Constipation (OIC) Treatment Market Analysis

    • 7.1 North America Opioid-Induced Constipation (OIC) Treatment Market, by Type

    • 7.2 North America Opioid-Induced Constipation (OIC) Treatment Market, by Application

    • 7.3 North America Opioid-Induced Constipation (OIC) Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Opioid-Induced Constipation (OIC) Treatment Market Analysis

    • 8.1 Europe Opioid-Induced Constipation (OIC) Treatment Market, by Type

    • 8.2 Europe Opioid-Induced Constipation (OIC) Treatment Market, by Application

    • 8.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Opioid-Induced Constipation (OIC) Treatment Market Analysis

    • 9.1 APAC Opioid-Induced Constipation (OIC) Treatment Market, by Type

    • 9.2 APAC Opioid-Induced Constipation (OIC) Treatment Market, by Application

    • 9.3 APAC Opioid-Induced Constipation (OIC) Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Opioid-Induced Constipation (OIC) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Opioid-Induced Constipation (OIC) Treatment Company Profiles

      • 11.1 AIKO Biotechnology

        • 11.1.1 AIKO Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.1.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Takeda Pharmaceutical Company Limited

        • 11.2.1 Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.2.3 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Salix Pharmaceuticals, Inc

        • 11.3.1 Salix Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.3.3 Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GlaxoSmithKline, Inc

        • 11.4.1 GlaxoSmithKline, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.4.3 GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Cubist Pharmaceuticals

        • 11.5.1 Cubist Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.5.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 AstraZeneca plc, Inc

        • 11.6.1 AstraZeneca plc, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.6.3 AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer, Inc

        • 11.7.1 Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.7.3 Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 SLA Pharma AG

        • 11.8.1 SLA Pharma AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification

        • 11.8.3 SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Opioid-Induced Constipation (OIC) Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Opioid-Induced Constipation (OIC) Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Opioid-Induced Constipation (OIC) Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate of Parenteral (Subcutaneous Injection) (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate of Drug Store (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate of Independent Pharmacies (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure North America Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Opioid-Induced Constipation (OIC) Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Opioid-Induced Constipation (OIC) Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Opioid-Induced Constipation (OIC) Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Opioid-Induced Constipation (OIC) Treatment Market Share, by Manufacturer in 2022

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Type (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Value, by Type (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Price Trend, by Type (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Type (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Value, by Type (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Price Trend, by Type (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Application (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Value, by Application (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Value Share, by Application (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Application (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Value, by Application (2017-2028)

    • Table China Opioid-Induced Constipation (OIC) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Type (2017-2028)

    • Table North America Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Application (2017-2028)

    • Table North America Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Opioid-Induced Constipation (OIC) Treatment Sales Value and Growth Rate (2017-2028)

    • Table AIKO Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AIKO Biotechnology Product Profiles, Application and Specification

    • Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Limited Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Salix Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Salix Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline, Inc Product Profiles, Application and Specification

    • Table GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cubist Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cubist Pharmaceuticals Product Profiles, Application and Specification

    • Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca plc, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca plc, Inc Product Profiles, Application and Specification

    • Table AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer, Inc Product Profiles, Application and Specification

    • Table Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SLA Pharma AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SLA Pharma AG Product Profiles, Application and Specification

    • Table SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US